Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B Vaccine

NCT00329576 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
632
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

GlaxoSmithKline